Worth Watching Stocks: Dendreon Corp. (NASDAQ:DNDN), Puma Biotechnology (NYSE:PBYI), Itron (NASDAQ:ITRI), Beacon Roofing Supply, Inc. (NASDAQ:BECN), Encore Capital Group, Inc. (NASDAQ:ECPG)

On July 30,2014 Dendreon Corporation (Nasdaq: DNDN) announced that its board of directors has appointed W. Thomas Amick as president and chief executive officer, effective immediately. Mr. Amick has also been appointed to the Company’s board of directors. Mr. Amick succeeds John H. Johnson, who previously announced his plans to step down as president and chief executive officer for personal reasons. Mr. Johnson will work with … Continue reading Worth Watching Stocks: Dendreon Corp. (NASDAQ:DNDN), Puma Biotechnology (NYSE:PBYI), Itron (NASDAQ:ITRI), Beacon Roofing Supply, Inc. (NASDAQ:BECN), Encore Capital Group, Inc. (NASDAQ:ECPG)

Biotech Volatile Stocks: Aastrom Biosciences Inc (NASDAQ:ASTM), Puma Biotechnology Inc (NYSE:PBYI), Oncolytics Biotech (NASDAQ:ONCY), Clovis Oncology (NASDAQ:CLVS), Idenix Pharmaceuticals (NASDAQ:IDIX)

Aastrom Biosciences Inc (NASDAQ:ASTM) posted its quarterly earnings results on Thursday. The company reported ($1.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by $0.34, AnalystRatings.NET reports. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of the company in a research note on Friday, March 14th. They now have a $5.00 price target on the … Continue reading Biotech Volatile Stocks: Aastrom Biosciences Inc (NASDAQ:ASTM), Puma Biotechnology Inc (NYSE:PBYI), Oncolytics Biotech (NASDAQ:ONCY), Clovis Oncology (NASDAQ:CLVS), Idenix Pharmaceuticals (NASDAQ:IDIX)

Mid Cap Bullish Stocks : Puma Biotechnology Inc (NYSE:PBYI), J2 Global Inc (NASDAQ:JCOM), Alnylam Pharmaceuticals (NASDAQ:ALNY), athenahealth (NASDAQ:ATHN)

Puma Biotechnology Inc (NYSE:PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at 11:20 a.m. PDT on Wednesday, May 14, at the Bank of America Merrill Lynch 2014 Health Care Conference. The conference will be held at the Encore at the Wynn in Las Vegas. Puma Biotechnology … Continue reading Mid Cap Bullish Stocks : Puma Biotechnology Inc (NYSE:PBYI), J2 Global Inc (NASDAQ:JCOM), Alnylam Pharmaceuticals (NASDAQ:ALNY), athenahealth (NASDAQ:ATHN)

Biotech Bearish Stocks: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Corcept Therapeutics Incorporated (NASDAQ:CORT), Puma Biotechnology Inc (NYSE:PBYI), Conatus Pharmaceuticals (NASDAQ:CNAT)

A Palo Alto startup will focus an $18 million VC investment on developing a drug to stop unexplained recurrent miscarriages. Nora Therapeutics is capitalizing on work started by cofounder Darryl Carter at Johns Hopkins University that led to development of Nora’s lead drug, NT-100. Nora is led by CEO Jeff Tong, who had been vice president of corporate and product development at Infinity Pharmaceuticals Inc. … Continue reading Biotech Bearish Stocks: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Corcept Therapeutics Incorporated (NASDAQ:CORT), Puma Biotechnology Inc (NYSE:PBYI), Conatus Pharmaceuticals (NASDAQ:CNAT)

Hot Stocks: FireEye Inc (NASDAQ:FEYE), Synageva BioPharma Corp (NASDAQ:GEVA), Intrexon Corp (NYSE:XON), Puma Biotechnology Inc (NYSE:PBYI)

FireEye, Inc. (NASDAQ: FEYE) filed a registration with the U.S. SEC to sell, from time to time, up to 13,282,316 shares of its Common Stock on behalf of Selling Shareholders. FireEye Inc (NASDAQ:FEYE) stock performance was 5.05% in last session and finished the day at $50.57. Traded volume was 6.04million shares in the last session and the average volume of the stock remained 3.61million shares. … Continue reading Hot Stocks: FireEye Inc (NASDAQ:FEYE), Synageva BioPharma Corp (NASDAQ:GEVA), Intrexon Corp (NYSE:XON), Puma Biotechnology Inc (NYSE:PBYI)

Losers to Watch: Autohome Inc (ADR) (NYSE:ATHM), Criteo (NASDAQ:CRTO), Puma Biotechnology Inc (NYSE:PBYI), Navistar International Corp (NYSE:NAV)

Autohome Inc. (NYSE:ATHM), the leading online destination for automobile consumers in China, today announced it filed its annual report on Form 20-F for the fiscal year ended December 31, 2013 with the Securities and Exchange Commission (the “SEC”) on March 31, 2014. Autohome Inc (ADR) (NYSE:ATHM) stock performance was -8.84% in last session and finished the day at $33.51. Traded volume was 777.8K shares in … Continue reading Losers to Watch: Autohome Inc (ADR) (NYSE:ATHM), Criteo (NASDAQ:CRTO), Puma Biotechnology Inc (NYSE:PBYI), Navistar International Corp (NYSE:NAV)